blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2804625

EP2804625 - METHODS AND COMPOSITIONS FOR EXPANDING IMMUNOSUPPRESSIVE T REGULATORY CELLS IN VITRO AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.08.2017
Database last updated on 26.06.2024
FormerExamination is in progress
Status updated on  25.11.2016
Most recent event   Tooltip18.08.2017Application deemed to be withdrawnpublished on 20.09.2017  [2017/38]
Applicant(s)For all designated states
Northeastern University
360 Huntington Avenue
900RP
Boston, Massachusetts 02115 / US
[2014/48]
Inventor(s)01 / SITKOVSKY, Michail
85 East India Row
Unit 24B
Boston Massachusetts 02110 / US
02 / OHTA, Akio
22 Glazer Road
Newton Massachusetts 02459 / US
03 / OHTA, Akiko
22 Glazer Road
Newton Massachusetts 02459 / US
 [2014/48]
Representative(s)Modiano, Micaela Nadia, et al
Modiano & Partners
Thierschstrasse 11
80538 München / DE
[2014/48]
Application number, filing date13738627.217.01.2013
WO2013US21948
Priority number, dateUS201261587329P17.01.2012         Original published format: US 201261587329 P
[2014/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013109759
Date:25.07.2013
Language:EN
[2013/30]
Type: A1 Application with search report 
No.:EP2804625
Date:26.11.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 25.07.2013 takes the place of the publication of the European patent application.
[2014/48]
Search report(s)International search report - published on:US25.07.2013
(Supplementary) European search report - dispatched on:EP28.09.2015
ClassificationIPC:A61K39/00, A61K35/17, C12N5/0783, A61K35/12
[2015/22]
CPC:
C12N5/0637 (EP,US); A61K35/17 (US); A61K39/4611 (EP);
A61K39/4621 (EP); A61K39/46433 (EP); A61K39/46434 (EP);
A61K2035/122 (EP,US); A61K2039/5158 (US); C12N2500/02 (EP,US);
C12N2501/01 (EP,US); C12N2501/2302 (EP,US); C12N2501/51 (EP,US);
C12N2501/515 (EP,US) (-)
Former IPC [2014/48]A61K39/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/48]
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR EXPANSION VON IMMUNSUPPRESSIVEN REGULATORISCHEN T-ZELLEN IN VITRO UND VERWENDUNGEN DAVON[2014/48]
English:METHODS AND COMPOSITIONS FOR EXPANDING IMMUNOSUPPRESSIVE T REGULATORY CELLS IN VITRO AND USES THEREOF[2014/48]
French:MÉTHODES ET COMPOSITIONS DE DÉVELOPPEMENT IN VITRO DE LYMPHOCYTES T RÉGULATEURS IMMUNOSUPPRESSEURS ET UTILISATIONS DE CELLES-CI[2014/48]
Entry into regional phase12.08.2014National basic fee paid 
12.08.2014Search fee paid 
12.08.2014Designation fee(s) paid 
12.08.2014Examination fee paid 
Examination procedure12.08.2014Examination requested  [2014/48]
25.04.2016Amendment by applicant (claims and/or description)
23.11.2016Despatch of a communication from the examining division (Time limit: M04)
04.04.2017Application deemed to be withdrawn, date of legal effect  [2017/38]
15.05.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/38]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.11.2016
Fees paidRenewal fee
13.01.2015Renewal fee patent year 03
27.01.2016Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.01.201705   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2010178299  (SITKOVSKY MICHAIL V [US], et al) [X] 8-12 * paragraphs [0119] , [0252]; table 1 *;
 [Y]WO2011126806  (UNIV PENNSYLVANIA [US], et al) [Y] 1-7,13-15 * claims 1,6,8,12,21-23 *;
 [X]  - K.S. CARSWELL ET AL, "Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2", CYTOTHERAPY, (20000101), vol. 2, no. 1, doi:10.1080/146532400539026, ISSN 1465-3249, pages 25 - 37, XP055184483 [X] 1-7,13-15 * page 26, column 2, paragraph 2; figures 1,3,4; tables 1,3 *

DOI:   http://dx.doi.org/10.1080/146532400539026
 [Y]  - GODFREY WAYNE R ET AL, "In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (20040715), vol. 104, no. 2, doi:10.1182/BLOOD-2004-01-0151, ISSN 0006-4971, pages 453 - 461, XP002457226 [Y] 1-7,13-15 * page 454, column 1, paragraph 1; figure 2 *

DOI:   http://dx.doi.org/10.1182/blood-2004-01-0151
 [Y]  - JEREMY BEN-SHOSHAN ET AL, "Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1[alpha]", EUROPEAN JOURNAL OF IMMUNOLOGY, (20080912), vol. 38, no. 9, doi:10.1002/eji.200838318, ISSN 0014-2980, pages 2412 - 2418, XP055184473 [Y] 1-7,13-15 * page 2413, paragraph 2; figures 1-2 *

DOI:   http://dx.doi.org/10.1002/eji.200838318
 [Y]  - J. S. BOOMER ET AL, "An Enigmatic Tail of CD28 Signaling", COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, (20100609), vol. 2, no. 8, doi:10.1101/cshperspect.a002436, pages a002436 - a002436, XP055184340 [Y] 1-7,13-15 * page 10, column 2, paragraph 2; figures 1-3 *

DOI:   http://dx.doi.org/10.1101/cshperspect.a002436
 [X]  - SITKOVSKY M V ET AL, "Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors", ANNUAL REVIEW OF IMMUNOLOGY, ANNUAL REVIEWS INC, US, vol. 22, doi:10.1146/ANNUREV.IMMUNOL.22.012703.104731, ISSN 0732-0582, (20040401), pages 657 - 682,V, (20031212), XP002579776 [X] 8-12 * page 663, column 1, paragraph 2; figure 4 *

DOI:   http://dx.doi.org/10.1146/ANNUREV.IMMUNOL.22.012703.104731
 [I]  - SITKOVSKY ET AL, "T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response", TRENDS IN IMMUNOLOGY, ELSEVIER LTD. * TRENDS JOURNALS, GB, vol. 30, no. 3, doi:10.1016/J.IT.2008.12.002, ISSN 1471-4906, (20090301), pages 102 - 108, (20090207), XP026002067 [I] 8-12 * page 103, column 1, paragraph 2; figure 1 *

DOI:   http://dx.doi.org/10.1016/j.it.2008.12.002
 [X]  - ALEXANDER CHOUKER ET AL, MOLECULAR MEDICINE, (20080101), vol. 14, no. 3-4, doi:10.2119/2007-00075.Chouker, ISSN 1076-1551, page 1, XP055184264 [X] 8-12 * page 117, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.2119/2007-00075.Chouker
International search[Y]US2006292164  (HORWITZ DAVID A [US]);
 [X]US2010178299  (SITKOVSKY MICHAIL V [US], et al);
 [A]  - ZHENG ET AL., "IL-2 is Essential for TGF-beta to Convert Naive CD4+CD25- Cells to CD25 +Foxp3+ Regulatory T Cells for Expansion of These Cells", THE JOURNAL OF IMMUNOLOGY, (20070215), vol. 178, no. 4, pages 2018 - 2027, XP002646457
 [A]  - MAHIC ET AL., "Differentiation of Naive CD4+ T cells into CD4+CD25+FOXP3+ Regulator T Cells by Continuous Antigen Stimulation", JOURNAL OF LEUKOCYTE BIOLOGY, (20080501), vol. 83, pages 1111 - 1117, XP055055463
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.